These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7107380)

  • 1. Combination adriamycin/misonidazole toxicity in V79 spheroids.
    Durand RE; Brown SM
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):603-5. PubMed ID: 7107380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of misonidazole to EMt6 and V79 spheroids.
    Franko AJ; Chapman JD; Koch CJ
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):737-9. PubMed ID: 7107407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.
    Durand RE; Chaplin DJ
    Br J Cancer; 1987 Aug; 56(2):103-9. PubMed ID: 3663461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of misonidazole to V79 spheroids and fragments of Dunning rat prostatic and human colon carcinomas in vitro: diffusion of oxygen and reactive metabolites.
    Franko AJ; Koch CJ
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1333-6. PubMed ID: 6469756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between the binding of [3H]misonidazole and AF-2 in Chinese hamster V79 spheroids.
    Olive PL; Rasey JS; Durand RE
    Radiat Res; 1986 Jan; 105(1):105-14. PubMed ID: 3945722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of 14C-misonidazole to hypoxic cells in V79 spheroids.
    Franko AJ; Chapman JD
    Br J Cancer; 1982 May; 45(5):694-9. PubMed ID: 7082555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of aerobic and hypoxic cells in a solid tumor to adriamycin and cyclophosphamide and interaction of the drugs with radiation.
    Tannock I
    Cancer Res; 1982 Dec; 42(12):4921-6. PubMed ID: 7139596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different sensitivity to cytotoxic agents of internal and external cells of spheroids composed of thioguanine-resistant and sensitive cells.
    Olive PL
    Br J Cancer; 1981 Jan; 43(1):85-92. PubMed ID: 7459243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in ultrastructure and function of hypoxic V79 fibroblast cells after treatment with misonidazole.
    Jacobson EA; Inch WR; Tustanoff ER
    Cancer; 1985 Feb; 55(4):751-9. PubMed ID: 2981602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity of hypoxic cell sensitizers in multicell spheroids.
    Sutherland RM; Bareham BJ; Reich KA
    Cancer Clin Trials; 1980; 3(1):73-83. PubMed ID: 7389039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long contact times of misonidazole on attached Chinese hamster V79 cells.
    Geard CR; Rutledge-Freeman MH
    Mutat Res; 1980 Jul; 78(3):289-94. PubMed ID: 7432365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. II. RSU 1069.
    Olive PL
    Br J Cancer; 1995 Mar; 71(3):537-42. PubMed ID: 7880736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: methotrexate, 5-fluorouracil and adriamycin.
    Tannock IF
    Br J Cancer; 1980 Dec; 42(6):861-70. PubMed ID: 7459220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The response of EMT6 tumor spheroids to combined treatment with misonidazole and either nitrogen mustard, adriamycin, or BCNU.
    Twentyman PR
    Cancer Clin Trials; 1980; 3(3):253-6. PubMed ID: 7438322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of combining the radiosensitizer misonidazole with cyclophosphamide in treating the murine Lewis lung tumor.
    Pedersen JE; Barron G; Meeker BE
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):651-3. PubMed ID: 7107392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometry studies of intracellular adriamycin in multicell spheroids in vitro.
    Durand RE
    Cancer Res; 1981 Sep; 41(9 Pt 1):3495-8. PubMed ID: 7260912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced cytotoxicity of antineoplastic agents following prolonged exposure to misonidazole.
    Roizin-Towle LA; Hall EJ
    Br J Cancer; 1981 Aug; 44(2):201-7. PubMed ID: 6168277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity of RSU 1069 in spheroids and murine tumors.
    Olive PL; Durand RE; Chaplin DJ
    Int J Radiat Oncol Biol Phys; 1987 Sep; 13(9):1361-6. PubMed ID: 3624045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic potential of misonidazole enhancement of alkylating agent cytotoxicity.
    Hirst DG; Brown JM
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):639-42. PubMed ID: 7107389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell fusion studies to examine the mechanism for etoposide resistance in Chinese hamster V79 spheroids.
    Luo C; Johnston PJ; MacPhail SH; Banáth JP; Oloumi A; Olive PL
    Exp Cell Res; 1998 Sep; 243(2):282-9. PubMed ID: 9743588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.